Viswanathan Palanisamy to Neoplasms
This is a "connection" page, showing publications Viswanathan Palanisamy has written about Neoplasms.
Connection Strength
0.954
-
HuR as a molecular target for cancer therapeutics and immune-related disorders. Adv Drug Deliv Rev. 2022 09; 188:114442.
Score: 0.364
-
Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer. Crit Rev Biochem Mol Biol. 2020 10; 55(5):409-424.
Score: 0.320
-
The Long (lncRNA) and Short (miRNA) of It: TGF?-Mediated Control of RNA-Binding Proteins and Noncoding RNAs. Mol Cancer Res. 2018 04; 16(4):567-579.
Score: 0.270